Oil-Dri Announces Record Results for the First Quarter of Fiscal Year 2025

GlobeNewswire Inc.

December 09, 2024 9:06PM GMT

CHICAGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year 2025.

 

First Quarter

(in thousands, except per share amounts)

Ended October 31,

 

2024

2023

Change

Consolidated Results

 

 

 

Net Sales

$

127,945

$

111,438

15

 %

Operating Income (Including Unallocated Corporate Expenses)

$

21,190

$

13,156

61

 %

Net Income

$

16,376

$

10,742

52

 %

EBITDA †

$

26,167

$

17,384

51

 %

Diluted EPS - Common

$

      2.25

$

      1.50

50

 %

Business to Business

 

 

 

Net Sales

$

48,415

$

39,161

24

 %

Segment Operating Income

$

17,110

$

11,123

54

 %

Retail and Wholesale

 

 

 

Net Sales

$

79,530

$

72,277

10

 %

Segment Operating Income

$

13,377

$

11,331

18

 %


† Please refer to Reconciliation of Non-GAAP Financial Measures below for a reconciliation of Non-GAAP items to the comparable GAAP measures.

 

Daniel S. Jaffee, President and Chief Executive Officer, stated, “I am happy to report that our fiscal year 2025 is off to a very positive start as we have once again achieved record results for consolidated net sales, gross profit, and net income in the first quarter.  We also delivered a 400-basis point year-over-year expansion in our gross margins, propelling our margins to 32%.   Our strong performance was driven by increased volumes, a favorable product mix, and improved operational efficiencies.  Solid execution of our growth strategies to establish a foothold in the growing renewable diesel and crystal cat litter markets helped us achieve this success.  Looking ahead, we believe we are well positioned to continue this upward trajectory.” 

Consolidated Results                                                                                                                
Consolidated net sales for the first quarter of fiscal 2025 reached a historic high of $127.9 million, or a 15% increase over the same period in the prior year.  This marks the 14th consecutive quarter of year-over-year sales growth.  Revenue increases were primarily driven by higher volumes across both operating segments, with significant sales gains generated from fluids purification, crystal cat litter, and co-packaged coarse litter products. Our recently acquired subsidiary, Ultra Pet Company, Inc. (“Ultra Pet”), delivered net sales of $6.0 million, or 5% of the total consolidated net sales increase over the prior year.  Organic growth from Oil-Dri’s other products drove the remaining increase in the Company’s topline.

Consolidated gross profit of $40.8 million, a record quarterly high, was achieved during the first three months of fiscal year 2025, representing a 32% gain over the prior year.  Gross margins expanded to 32% in the current year from 28% in the first quarter of fiscal year 2024.  Oil-Dri's efforts to grow volume, improve product mix, and enhance operating efficiencies proved successful during the quarter.  This marks the ninth consecutive quarter of year-over-year gross margin expansion.  During the three months ended October 31, 2024, domestic cost of goods per ton remained flat compared to the prior year. 

Selling, general and administrative expenses (“SG&A”) were $19.6 million during the first quarter of fiscal 2025 compared to $17.8 million for the same period last year.  This $1.8 million, or 10%, increase reflects higher compensation costs and a preliminary foreign value-added tax assessment, in addition to other operating segment costs.   

In the first quarter of fiscal year 2025, consolidated operating income increased to $21.2 million, or by 61%, compared to the first quarter of fiscal year 2024.  Higher sales volumes combined with improved product mix offset elevated SG&A costs.

Total other expense, net was $1.0 million for the three months ended October 31, 2024, compared to $300,000 in the same period last year.  This increase was mainly due to interest expense on the debt assumed for the Ultra Pet acquisition, along with an additional reserve for the capacity modification project at the Company’s sole landfill located in Georgia. The modification work is expected to be completed during fiscal year 2025.

Consolidated net income reached a record $16.4 million in the first quarter of fiscal 2025 from $10.7 million in the same period in fiscal 2024, reflecting a 52% improvement over the prior year.

Cash and cash equivalents for the three month period ending October 31, 2024, totaled $12.5 million compared to $23.5 million at the end of fiscal year 2024.  During the first quarter of fiscal 2025, Oil-Dri continued its significant investment in manufacturing infrastructure improvements.  In addition, the Company paid down $5.0 million of the $10.0 million revolving credit facility that was used to partially fund the acquisition of Ultra Pet.  Other significant uses of cash include the payment of dividends and the purchase of treasury shares that were surrendered by teammates to pay taxes related to the vesting of restricted stock awards.

Product Group Review
The Business to Business Products (“B2B”) Group’s  first quarter of fiscal year 2025 revenues were a record $48.4 million, or 24% greater than the prior year, primarily driven by an increase in volume and, to a lesser extent, by higher prices.  Elevated sales from fluids purification and agricultural products offset slight sales declines in the animal health business.  During the first quarter of fiscal 2025, revenues from fluids purification products reached an all-time high of  $30.1 million, or an 37% increase over the prior year.  The Company experienced increased demand of its Metal X and Metal Z products as a result of recently established renewable diesel plants within North America.  Sales of fluids purification products in EMEA1, Latin America, and Asia also increased during the three month period ended October 31, 2024, compared to the same period last year.  The agricultural products business achieved record quarterly net sales of $11.6 million, or a 12% increase over the prior year.  This growth was mainly fueled by higher demand from key customers who resumed typical purchasing patterns after working through inventory surpluses, as well as by elevated prices.  Amlan, the Company’s animal health business, generated $6.2 million in sales, or a 3% decline from the prior year. The decrease was primarily concentrated in Asia due to the sell-off of existing inventory in China that occurred in the first quarter of fiscal year 2024 as part of the transition to a master distributor.  However, double-digit topline growth was achieved within Latin America and North America where increased demand, in conjunction with elevated prices, helped drive sales improvement.

During the first quarter of fiscal year 2025, SG&A costs within the B2B Products Group increased by $700,000 or 20%, compared to the same period last year.  This was mainly driven by a preliminary foreign value-added tax assessment and higher research and development costs.

Operating income for the B2B Products Group was $17.1 million in the first quarter of fiscal year 2025 compared to $11.1 million in the same period of fiscal year 2024, reflecting a 54% increase.  This growth can be attributed to higher sales and a favorable product mix, partially offset by increased SG&A expenses.

The Retail and Wholesale (“R&W”) Products Group’s first quarter revenues reached an all-time high of $79.5 million, a 10% increase over the prior year.  The acquisition of Ultra Pet contributed 8% of the total R&W sales growth, and the remaining 2% can be attributed to organic topline growth from increased demand for other products within the operating segment. During the first quarter of fiscal 2025, the Company increased distribution of its Cat’s Pride and Ultra crystal litter products and is beginning to realize synergies related to the acquisition.  Total domestic clay-based cat litter sales, excluding the Company’s co-packaged coarse cat litter business, were $53.8 million, or 2% lower than the prior year.  Conversely, revenues of co-packaged coarse cat litter increased by $2.1 million, or 78%, compared to last year due to higher demand.  In the first quarter of fiscal year 2024, a cyberattack disrupted a key customer’s ability to place and receive orders, which negatively impacted sales of Oil-Dri’s co-packaged coarse litter.  However, the cyber event boosted sales of the Company’s branded and private label coarse items and is currently influencing year-over-year comparisons for both domestic clay and co-packaged litter products.  Although total domestic clay litter revenues declined, Oil-Dri continued to experience topline growth of its EPA-approved Cat’s Pride Antibacterial Clumping Litter, which is currently sold at large brick and mortar and e-commerce retailers.  In addition, new distribution of other clay litter products and accessories was achieved at both new and existing customers.  Domestic industrial and sports product revenues were $11.0 million in the first quarter of fiscal 2025, or 4% higher than the same period in the prior year, driven by increased demand.  The Company’s Canadian subsidiary experienced sales declines as a result of softer revenues from cat litter, partially offset by sales growth from industrial floor absorbent products.

During the first quarter of fiscal 2025, SG&A expenses within the R&W Products Group increased by $1.0 million, or 21% over the prior year.  This increase was primarily driven by higher compensation costs, a significant credit reserve for several customer bankruptcies, acquisition-related amortization of intangible assets, and increased research and development costs.  These higher expenses were partially offset by lower advertising costs.  Oil-Dri expects advertising expenditures for the full fiscal year 2025 to be lower than fiscal year 2024. 

Operating income for the R&W Products Group reached $13.4 million in the first quarter of fiscal year 2025 compared to $11.3 million in the prior year, reflecting an 18% increase.  This growth can be attributed to higher sales volumes, including the incremental business from the Ultra Pet acquisition, partially offset by elevated SG&A expenses.

The Company will host its first quarter of fiscal year 2025 earnings discussion and its 2024 Annual Meeting of Stockholders virtually via a live webcast on Wednesday, December 11, 2024 at 9:30 a.m. Central Time. Participation details are available on the Company’s website’s Events page.

1EMEA is the region including Europe, the Middle East, and Africa.
“Oil-Dri”, “Cat’s Pride”, “Metal X”, “Metal Z”, “Amlan”, and “Ultra” are registered trademarks of Oil-Dri Corporation of America and its subsidiaries. 

About Oil-Dri Corporation of America
Oil-Dri Corporation of America is a leading manufacturer and supplier of specialty sorbent products for the pet care, animal health and nutrition, fluids purification, agricultural ingredients, sports field, industrial and automotive markets.  Oil-Dri is vertically integrated which enables the Company to efficiently oversee every step of the process from research and development to supply chain to marketing and sales. With over 80 years of experience, the Company continues to fulfill its mission to Create Value from Sorbent Minerals

Forward-Looking Statements
Certain statements in this press release may contain forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our current expectations, estimates, forecasts and projections about our future performance, our business, our beliefs and our management’s assumptions. In addition, we, or others on our behalf, may make forward-looking statements in other press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. Forward-looking statements can be identified by words such as “expect,” “outlook,” “forecast,” “would,” “could,” “should,” “project,” “intend,” “plan,” “continue,” “believe,” “seek,” “estimate,” “anticipate,” “may,” “assume,” “potential,” “strive,” and similar references to future periods.

Such statements are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially, including, but not limited to, those described in Item 1A, “Risk Factors” of our Quarterly Report on Form 10-Q for the quarter ended October 31, 2024 and our most recent Annual Report on Form 10-K and from time to time in our other filings with the Securities and Exchange Commission. Should one or more of these or other risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, intended, expected, believed, estimated, projected, planned or otherwise expressed in any forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except to the extent required by law, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this press release, whether as a result of new information, future events, changes in assumptions, or otherwise.

Non-GAAP Financial Measures
To supplement our consolidated financial statements prepared in accordance with generally accepted accounting principles (“GAAP”), we provide certain non-GAAP financial measures in this press release as supplemental financial metrics. In particular, EBITDA is a non-GAAP financial measure provided herein. We provide a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP financial measure below.

The non-GAAP financial measures we use may not be the same or calculated in the same manner as those used and calculated by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for our financial results prepared and reported in accordance with GAAP. We believe that certain non-GAAP measures may be helpful to investors and others in understanding and evaluating our operating results, and we urge investors to review the reconciliation of non-GAAP financial measures to the comparable GAAP financial measures included in this release, and not to rely on any single financial measure to evaluate our business.

Contact:
Leslie A. Garber
Director of Investor Relations
Oil-Dri Corporation of America
InvestorRelations@oildri.com 
(312) 321-1515

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

 

2024

 

% of Sales

 

2023

 

% of Sales

Net Sales

 

$

127,945

 

 

100.0

 %

 

$

111,438

 

 

100.0

 %

Cost of Goods Sold

 

 

(87,165

)

 

(68.1

)%

 

 

(80,447

)

 

(72.2

)%

Gross Profit

 

 

40,780

 

 

31.9

 %

 

 

30,991

 

 

27.8

 %

Selling, General and Administrative Expenses

 

 

(19,590

)

 

(15.3

)%

 

 

(17,835

)

 

(16.0

)%

Operating Income

 

 

21,190

 

 

16.6

 %

 

 

13,156

 

 

11.8

 %

Other Expense, Net

 

 

(988

)

 

(0.8

)%

 

 

(326

)

 

(0.3

)%

Income Before Income Taxes

 

 

20,202

 

 

15.8

 %

 

 

12,830

 

 

11.5

 %

Income Taxes Expense

 

 

(3,826

)

 

(3.0

)%

 

 

(2,088

)

 

(1.9

)%

Net Income

 

 

16,376

 

 

12.8

 %

 

 

10,742

 

 

9.6

 %

 

 

 

 

 

 

 

 

 

Net Income Per Share:         

Basic Common

$

2.43

 

 

 

 

$

1.61

 

 

 

                                       

Basic Class B

$

1.82

 

 

 

 

$

1.21

 

 

 

                                       

Diluted Common

$

2.25

 

 

 

 

$

1.50

 

 

 

                                            

Diluted Class B

$

1.82

 

 

 

 

$

1.21

 

 

 

Avg Shares Outstanding:     

Basic Common

 

4,922

 

 

 

 

 

4,827

 

 

 

                                       

Basic Class B

 

1,984

 

 

 

 

 

1,967

 

 

 

                                                

Diluted Common

 

6,906

 

 

 

 

 

6,794

 

 

 

                                       

Diluted Class B

 

1,984

 

 

 

 

 

1,967

 

 

 


CONSOLIDATED BALANCE SHEETS

 

 

 

(in thousands, except per share amounts)

 

 

 

 

As of October 31,

 

As of July 31,

 

2024

 

2024

Current Assets

 

 

 

Cash and Cash Equivalents

$

                   12,506

 

$

             23,481

Accounts Receivable, Net

 

                      70,544

 

 

                62,171

Inventories, Net

 

                      56,025

 

 

                54,236

Prepaid Expenses and Other Assets

 

                        5,040

 

 

                  7,270

Total Current Assets

 

                    144,115

 

 

              147,158

Property, Plant and Equipment, Net

 

                    137,947

 

 

              137,796

Other Assets

 

                      68,109

 

 

                69,651

Total Assets

$

                 350,171

 

$

           354,605

 

 

 

 

Current Liabilities

 

 

 

Current Maturities of Notes Payable

$

                      1,000

 

$

                1,000

Accounts Payable

 

                      13,824

 

 

                15,009

Dividends Payable

 

                        2,098

 

 

                  2,096

Other Current Liabilities

 

                      37,919

 

 

                48,572

Total Current Liabilities

 

                      54,841

 

 

                66,677

Noncurrent Liabilities

 

 

 

Notes Payable

 

                      44,777

 

 

                49,774

Other Noncurrent Liabilities

 

                      26,561

 

 

                27,566

Total Noncurrent Liabilities

 

                      71,338

 

 

                77,340

Stockholders' Equity

 

                    223,992

 

 

              210,588

Total Liabilities and Stockholders' Equity

$

                 350,171

 

$

           354,605

 

 

 

 

Book Value Per Share Outstanding

$

                      32.43

 

$

                30.69


CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

For the Three Months Ended

 

October 31,

 

2024

 

2023

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

Net Income

$

             16,376

 

 

$

             10,742

 

Adjustments to reconcile net income to net cash

 

 

 

provided by operating activities:

 

 

 

Depreciation and Amortization

 

                  5,381

 

 

 

                  4,368

 

Increase in Accounts Receivable

 

                (9,020

)

 

 

                (1,487

)

Increase in Inventories

 

                (2,033

)

 

 

                (1,374

)

Decrease in Prepaid Expenses

 

                  2,228

 

 

 

                     154

 

Increase (Decrease) in Accounts Payable

 

                  1,889

 

 

 

                (1,289

)

Decrease in Accrued Expenses

 

                (6,117

)

 

 

                (4,365

)

Other

 

                  2,215

 

 

 

                  1,815

 

Total Adjustments

 

                (5,457

)

 

 

                (2,178

)

Net Cash Provided by Operating Activities

 

                10,919

 

 

 

                  8,564

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

Capital Expenditures

 

              (12,817

)

 

 

                (8,064

)

Net Cash Used in Investing Activities

 

              (12,817

)

 

 

                (8,064

)

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

Principal Payments on Notes Payable

 

                (5,000

)

 

 

                        —

 

Dividends Paid

 

                (2,096

)

 

 

                (1,927

)

Purchases of Treasury Stock

 

                (1,984

)

 

 

                   (872

)

Net Cash Used In Financing Activities

 

                (9,080

)

 

 

                (2,799

)

 

 

 

 

Effect of exchange rate changes on Cash and Cash Equivalents

 

                          3

 

 

 

                     124

 

 

 

 

 

Net Decrease in Cash and Cash Equivalents

 

              (10,975

)

 

 

                (2,175

)

Cash, Cash Equivalents, and Restricted Cash, Beginning of Period

 

                24,481

 

 

 

                31,754

 

Cash, Cash Equivalents and Restricted Cash, End of Period

$

             13,506

 

 

$

             29,579

 


RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

 

 

(in thousands)

 

First Quarter

 

Ended October 31,

 

2024

 

2023

GAAP: Net Income

$

16,376

 

 

$

10,742

 

Depreciation and Amortization

$

5,381

 

 

$

4,368

 

Interest Expense

$

734

 

 

$

361

 

Interest Income

$

(150

)

 

$

(175

)

Income Tax Expense

$

3,826

 

 

$

2,088

 

EBITDA

$

26,167

 

 

$

17,384

 

 

 

 

 

 

 

 

 

This press release was published by a CLEAR® Verified individual.